openPR Logo
Press release

Geographic Atrophy Treatment Market is expected to grow steeply with a CAGR of ~30%, companies like Roche, NGM Biopharmaceuticals, Apellis Pharmaceuticals etc among others fueling the market

06-16-2022 06:47 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Geographic Atrophy Market

Geographic Atrophy Market

(Albany, US) DelveInsight's Geographic Atrophy Market Analysis Report proffers a comprehensive outlay of the Geographic Atrophy Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the Geographic Atrophy market analysis in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan).

The report covers the Geographic Atrophy market trends covering key pharmaceutical companies in the market, upcoming as well as Geographic Atrophy marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth.

Know more about Geographic Atrophy Market Report: https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the significant Geographic Atrophy Market Report Highlights:
• Increase in Geographic Atrophy market size anticipated for the study period 2019-2032 at a CAGR of ~30%.
• Globally, more than 5 million people are affected by Geographic Atrophy.
• In the year 2020, the total prevalent case of Geographic Atrophy was 2,969,911 cases in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2019-2032.
• In the 7MM, the total treated cases of Geographic Atrophy were 1,267,314 cases in 2020.
• There are currently no approved Geographic Atrophy treatments. Several major players such as Apellis Pharmaceuticals, NGM Biopharmaceuticals, Roche, and many others are developing therapies for the Geographic Atrophy treatment.
• NGM Biopharmaceuticals is currently conducting the Phase 2 CATALINA study, a multicenter, randomized, double-masked, sham-controlled clinical trial, to assess the safety and efficacy of intravitreal injections (IVT) of NGM621 in patients with Geographic Atrophy secondary to age-related macular degeneration (AMD).
• NGM completed a multi-centre evaluation of NGM621 in an open-label, single-dose, and multiple-dose escalation study in participants with Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT04014777).

Get more comprehensive insights into how Geographic Atrophy epidemiological trends are impacting current and forecasted Geographic Atrophy market @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Geographic Atrophy Companies:
• Iveric Bio (formerly Ophthotech Corporation)
• Apellis Pharmaceuticals
• Hemera Biosciences
• Allegro Ophthalmics
• Stealth BioTherapeutics
• Alkeus Pharmaceuticals
• Gyroscope Therapeutics
• Regenerative Patch Technologies
• Roche/Genentech
• Ionis Pharmaceuticals/Roche
• CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics)
• Janssen Research & Development
• And Many Others

Do you want to know how much market share the emerging therapies are going to capture by 2032? Contact @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The launch of the emerging therapies is expected to significantly impact the Geographic Atrophy treatment scenario in the upcoming years:-

Some of Geographic Atrophy Drugs Covered:
• Zimura (avacincaptad pegol)
• Pegcetacoplan
• HMR59/AAVCAGsCD59
• Risuteganib/ALG-1001/Luminate
• Elamipretide
• ALK-001
• GT005
• CPCB-RPE1
• RO7171009/RG6147
• IONIS-FB-LRx
• OpRegen
• Palucorcel/CNTO 2476
• And Many Others

Know more about the collaborations, tie-ups, and therapies launch @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Geographic Atrophy
3. Competitive Intelligence Analysis for Geographic Atrophy
4. Geographic Atrophy: Market Overview at a Glance
5. Geographic Atrophy: Disease Background and Overview
6. Patient Journey
7. Geographic Atrophy Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Geographic Atrophy Treatment
11. Marketed Products
12. Emerging Therapies
13. Geographic Atrophy: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Geographic Atrophy
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities

Request for Free Sample Report: https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Latest Reports:

3D Cardiac Mapping System Market
https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Acanthamoeba Keratitis Market
https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adult Growth Hormone Deficiency Market
https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Advanced Cancer Pain Management Market
https://www.delveinsight.com/report-store/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Apheresis Market
https://www.delveinsight.com/report-store/apheresis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Arteriovenous fistula Market
https://www.delveinsight.com/report-store/arteriovenous-fistula-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automated external defibrillators (AEDs) Market
https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Balloon Catheters Market
https://www.delveinsight.com/report-store/balloon-catheters-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Calciphylaxis Market
https://www.delveinsight.com/report-store/calciphylaxis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cerebral Aneurysm Market
https://www.delveinsight.com/report-store/cerebral-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Idiopathic Urticaria Market
https://www.delveinsight.com/report-store/chronic-idiopathic-urticaria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Geographic Atrophy Treatment Market is expected to grow steeply with a CAGR of ~30%, companies like Roche, NGM Biopharmaceuticals, Apellis Pharmaceuticals etc among others fueling the market here

News-ID: 2654130 • Views:

More Releases from DelveInsight Business Research

Alpha-1 Antitrypsin Deficiency Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight
Alpha-1 Antitrypsin Deficiency Pipeline 2025: MOA and ROA Insights, Clinical Tri …
Alpha-1 Antitrypsin Deficiency pipeline constitutes 12+ key companies continuously working towards developing 12+ Alpha-1 Antitrypsin Deficiency treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Alpha-1 Antitrypsin Deficiency Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Alpha-1 Antitrypsin Deficiency Market. The Alpha-1 Antitrypsin Deficiency Pipeline report embraces in-depth commercial
Alopecia Areata Market Expected to Gain Momentum Through 2034, According to DelveInsight
Alopecia Areata Market Expected to Gain Momentum Through 2034, According to Delv …
The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alopecia Areata pipeline products will significantly revolutionize the Alopecia Areata market dynamics. DelveInsight's "Alopecia Areata Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United
Acne Vulgaris Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight
Acne Vulgaris Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acne Vulgaris pipeline constitutes 20+ key companies continuously working towards developing 22+ Acne Vulgaris treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acne Vulgaris Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
Stargardt Disease Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight
Stargardt Disease Market Dynamics Indicate Upward Trajectory Through 2034, Repor …
The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products will significantly revolutionize the Stargardt Disease market dynamics. DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United

All 5 Releases


More Releases for Geographic

Geographic Information System (GIS) Software Global Market Report 2024 - Geograp …
"The Business Research Company recently released a comprehensive report on the Global Geographic Information System (GIS) Software Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The
Cybersecurity Market Regional Analysis | Evaluating Geographic Trends
Cybersecurity Market Scope and Overview In the digital era, where information is the new currency, cybersecurity emerges as a paramount concern for individuals, businesses, and governments alike. With the exponential growth of cyber threats, the global Cybersecurity Market has witnessed a surge in demand for innovative solutions and services to safeguard sensitive data and critical infrastructure. This report delves into a comprehensive analysis of the cybersecurity market, covering key players, market
Geographic Information System - Comprehensive Analysis
GIS is used to power millions of decisions every day all over the world, such as examining crime patterns, pinpointing novel store locations, directing in-car navigation, and predicting and forecasting the weather, among others. The growing demand for location-based analytics among businesses to enhance operational efficiency and improve decision-making is driving the market growth. Similarly, the necessity to combine traditional data with three-dimensional data to get valuable insights from location-based
Automobile Accessories Market: Charting New Geographic Territory
An extensive analysis of the Automobile Accessories market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy. It also analyzes the company’s strategy in the light of Porter’s
Geographic Atrophy - Pipeline Review, H2 2018 - ResearchByMarkets.com
"Geographic Atrophy - Pipeline Review, H2 2018", provides an overview of the Geographic Atrophy (Ophthalmology) pipeline landscape. Geographic atrophy is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retina which can lead to a loss of visual function over time. Symptoms include difficulty during reading. Risk factors include smoking, thyroid hormones or antacids and in patients with coronary heart diseases and cataract
MapsOfWorld.com partners with National Geographic Maps
MapsOfWorld.com has proudly partnered with National Geographic Maps to sell National Geographic maps and atlases in the United States. All wall maps are available at an initial discount of 15%, along with additional discounts on bulk items ordered by corporations and schools. Range of products available for sale include: paper and laminated wall maps, mural (wall paper) maps, travel maps and atlases. Wall maps are available in National Geographic’s three